Mangangot, Mark Caleb R.

HRN: 24-14-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
12/01/2023
12/07/2023
IV
14 Mg
Once A Day
Neonatal Sepsis
Waiting Final Action 
12/01/2023
AMPICILLIN 500MG (VIAL)
12/01/2023
12/08/2023
IV
140 Mg
BID
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: